Four molecules, priced against each other
Compounded semaglutide, compounded tirzepatide, compounded liraglutide and retatrutide all appear on the same shop shelf with a figure attached, alongside a brand-name tirzepatide route fulfilled through the manufacturer direct pharmacy. Very little on this roster lets a reader see what switching molecule actually costs.
The spread is instructive. Brand tirzepatide costs several times the compounded version, the daily liraglutide sits above the weekly tirzepatide, and the compounded semaglutide is the cheapest thing on the shelf. Those relationships are hard to see anywhere the products are sold on separate pages.
The headline is a member rate
Every product page states the membership charge, that it renews automatically until cancelled, and that member pricing, waived visit fees and free shipping apply only while it is active. A one-time order instead pays the list price plus a visit fee plus shipping, every single time.
So the advertised figure is neither the list price nor the bill. A reader comparing it against a competitor all-in monthly rate is comparing a discounted medication line against a total. This page records the membership as a separate charge with its own figure so that the two halves stay visible.
Retatrutide on the same shelf
The shop prices retatrutide and its own listing describes the compound as investigational. That is a molecule with no approved finished product behind it, sold beside two that have one and one that is the approved product itself.
It is disclosed here rather than scored. A reader who does not know the difference between a compounded version of an approved drug and a compounded version of an unapproved one will not learn it from a shelf that displays both the same way.
Two entry prices that do not match
The homepage advertises a GLP-1 starting figure well below the cheapest compounded rate on the shop shelf. The two pages do not describe the same entry price, and nothing reconciles them.
Otherwise the disclosure is thin in the usual places. No compounding pharmacy is named; the site names the manufacturer pharmacy for the brand route only. No individual prescribing clinician or medical director is identified, despite physician-led being the framing on every page. It does state it prescribes in all fifty states.
ElitePhysiqMD's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $179.10/mothe member auto-refill rate, ten percent off the $199.00 list price; a one-time order is $199.00 plus a $49.00 visit fee and $30.00 shipping, and the membership behind the member rate is charged separately | September 2026source |
| Tirzepatide (compounded) | $315/mothe member auto-refill rate, ten percent off the $350.00 list price; a one-time order is $350.00 plus a $49.00 visit fee and $30.00 shipping | September 2026source |
| Liraglutide (compounded) | $382.50/mothe member rate printed on the shop listing for the compounded daily injection | September 2026source |
| Retatrutide (compounded) | $499/mothe member rate printed on the shop listing; the listing itself calls retatrutide an investigational compound, which is not an approved medicine | September 2026source |
| Tirzepatide (brand) | $1,071/mothe figure the shop listing prints for the brand-name route it fulfils through LillyDirect Pharmacy, alongside its own compounded rows | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 283 providers reviewed here are paid partners today; the other 279 are not. See how this works.
See ElitePhysiqMD's current price →Good fit if
- Readers weighing one GLP-1 molecule against another who want them priced on the same shelf.
- Patients who want a brand-name route and a compounded route from one service.
- Anyone who wants the membership charge, its renewal behaviour and the benefits it gates stated explicitly.
- Readers who order often enough that a waived visit fee and free shipping outweigh a recurring membership.
Look elsewhere if
- Anyone comparing headline figures across sellers, because this headline is a member rate with a recurring charge behind it.
- Patients uncomfortable buying an investigational compound from a shelf that displays it like an approved one.
- Readers who need the compounding pharmacy named.
- Occasional buyers, for whom the one-time price plus visit fee plus shipping is the relevant number and is considerably higher.
How this review was verified
- Read the shop shelf and both GLP-1 product pages at their source URLs, mapping every figure to the product heading it sits under rather than to the nearest name in reading order.
- Recorded the member rate for each molecule with the list price, the visit fee and the shipping charge written into the qualifier.
- Recorded the membership as a separate recurring charge with its own figure, taken verbatim from the product page.
- Recorded the brand-name route as a brand row rather than folding it into the compounded rows.
- Pulled all 3,677 rows of the FDA warning-letter table and filtered them locally with a known-positive and a nonsense-string control in the same run; no letter found.